Unpacking the Latest Options Trading Trends in AbbVie

view original post

Consistent in their evaluation, an analyst from BMO Capital keeps a Outperform rating on AbbVie with a target price of $180. Consistent in their evaluation, an analyst from Barclays keeps a Overweight …